|
|
|
Schizophrenia Clinical Trials |
|
Thank you for your interest in clinical trials for Schizophrenia.
Please click "Search" to find Schizophrenia clinical trials and medical research studies or read below for information on Schizophrenia diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 6 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Recently Released From Jail - NCT01157351-
Conditions: Schizophrenia
Location: Wharton, TX
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-06519
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New Haven, CT
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-10032
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-14623
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Rochester, NY
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-19104
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Philadelphia, PA
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-21061
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Glen Burnie, MD
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-27509
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Butner, NC
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-27599
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Chapel Hill, NC
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-30912
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Augusta, GA
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-33316
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Miami, FL
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-44141
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Brecksville, OH
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-45267
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Cincinnati, OH
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-48201
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Detroit, MI
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-52242
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Iowa City, IA
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-55454
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Minneapolis, MN
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-64128
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Kansas City, MO
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-67207
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Wichita, KS
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-68131
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Omaha, NE
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-75235
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Dallas, TX
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-77488
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Wharton, TX
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-78711
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Waco, TX
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-92324
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Colton, CA
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-94304
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Palo Alto, CA
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-98493
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Tacoma, WA
- A Comparison of Long-acting Injectable Medications for Schizophrenia - NCT01136772-99204
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Spokane, WA
- A Dose-Response Study of Modafinil Effects on Cognition in Healthy Adults and in Schizophrenia Patients - NCT00711464-95817
Conditions: Schizophrenia
Location: Sacramento, CA
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence - NCT00737256-80220
Conditions: Schizophrenia - Cocaine Dependence
Location: Denver, CO
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-11516
Conditions: Schizophrenia
Location: Cedarhurst, NY
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-14615
Conditions: Schizophrenia
Location: Rochester, NY
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-19131
Conditions: Schizophrenia
Location: Philadelphia, PA
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-30308
Conditions: Schizophrenia
Location: Atlanta, GA
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-33319
Conditions: Schizophrenia
Location: Fort Lauderdale, FL
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-38119
Conditions: Schizophrenia
Location: Memphis, TN
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-39232
Conditions: Schizophrenia
Location: Flowood, MS
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-44094
Conditions: Schizophrenia
Location: Willoughby, OH
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-46222
Conditions: Schizophrenia
Location: Indianapolis, IN
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-60194
Conditions: Schizophrenia
Location: Hoffman Estates, IL
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-60640
Conditions: Schizophrenia
Location: Chicago, IL
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-63139
Conditions: Schizophrenia
Location: St Louis, MO
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-63141
Conditions: Schizophrenia
Location: Creve Coeur, MO
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-70601
Conditions: Schizophrenia
Location: Lake Charles, LA
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-75115
Conditions: Schizophrenia
Location: Desoto, TX
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-77008
Conditions: Schizophrenia
Location: Houston, TX
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-78754
Conditions: Schizophrenia
Location: Austin, TX
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-90723
Conditions: Schizophrenia
Location: Paramount, CA
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-92025
Conditions: Schizophrenia
Location: Escondido, CA
- A Long-Term, Open-Label, Study on Schizophrenia - NCT01129674-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) - NCT00677898-21201
Conditions: Schizophrenia - Psychotic Disorders
Location: Baltimore, MD
- A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis - NCT00591318-10032
Conditions: Psychosis - Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients - NCT01091506-
Conditions: Schizophrenia
Location: Boston, MA
- A Self-Management Program for Adults With Both Schizophrenia and a Co-Occurring Medical Condition - NCT00525304-21201
Conditions: Schizophrenia
Location: Baltimore, MD
- A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients - NCT00725855-80262
Conditions: Schizophrenia
Location: Denver, CO
- A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents - NCT01143077-
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Salt Lake City, UT
- A Study in Schizophrenia Patients - NCT01086748-11516
Conditions: Schizophrenia
Location: Cedarhurst, NY
- A Study in Schizophrenia Patients - NCT01086748-14615
Conditions: Schizophrenia
Location: Rochester, NY
- A Study in Schizophrenia Patients - NCT01086748-19131
Conditions: Schizophrenia
Location: Philadelphia, PA
- A Study in Schizophrenia Patients - NCT01086748-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Study in Schizophrenia Patients - NCT01086748-30308
Conditions: Schizophrenia
Location: Atlanta, GA
- A Study in Schizophrenia Patients - NCT01086748-33021
Conditions: Schizophrenia
Location: Hollywood, FL
- A Study in Schizophrenia Patients - NCT01086748-38119
Conditions: Schizophrenia
Location: Memphis, TN
- A Study in Schizophrenia Patients - NCT01086748-39232
Conditions: Schizophrenia
Location: Flowood, MS
- A Study in Schizophrenia Patients - NCT01086748-44094
Conditions: Schizophrenia
Location: Willoughby, OH
- A Study in Schizophrenia Patients - NCT01086748-46222
Conditions: Schizophrenia
Location: Indianapolis, IN
- A Study in Schizophrenia Patients - NCT01086748-60194
Conditions: Schizophrenia
Location: Hoffman Estates, IL
- A Study in Schizophrenia Patients - NCT01086748-60640
Conditions: Schizophrenia
Location: Chicago, IL
- A Study in Schizophrenia Patients - NCT01086748-63139
Conditions: Schizophrenia
Location: St Louis, MO
- A Study in Schizophrenia Patients - NCT01086748-63141
Conditions: Schizophrenia
Location: Creve Coeur, MO
- A Study in Schizophrenia Patients - NCT01086748-70601
Conditions: Schizophrenia
Location: Lake Charles, LA
- A Study in Schizophrenia Patients - NCT01086748-75115
Conditions: Schizophrenia
Location: Desoto, TX
- A Study in Schizophrenia Patients - NCT01086748-77008
Conditions: Schizophrenia
Location: Houston, TX
- A Study in Schizophrenia Patients - NCT01086748-78754
Conditions: Schizophrenia
Location: Austin, TX
- A Study in Schizophrenia Patients - NCT01086748-90723
Conditions: Schizophrenia
Location: Paramount, CA
- A Study in Schizophrenia Patients - NCT01086748-92025
Conditions: Schizophrenia
Location: Escondido, CA
- A Study in Schizophrenia Patients - NCT01086748-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-08046
Conditions: Schizophrenia
Location: Willingboro, NJ
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-10035
Conditions: Schizophrenia
Location: New York, NY
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-11516
Conditions: Schizophrenia
Location: Cedarhurst, NY
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-60169
Conditions: Schizophrenia
Location: Hoffman Estates, IL
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-60640
Conditions: Schizophrenia
Location: Chicago, IL
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-63139
Conditions: Schizophrenia
Location: St Louis, MO
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-70601
Conditions: Schizophrenia
Location: Lake Charles, LA
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-75115
Conditions: Schizophrenia
Location: Desoto, TX
- A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-08046
Conditions: Schizophrenia
Location: Willingboro, NJ
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-08078
Conditions: Schizophrenia
Location: Runnemede, NJ
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-08755
Conditions: Schizophrenia
Location: Toms River, NJ
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-10304
Conditions: Schizophrenia
Location: Staten Island, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-10305
Conditions: Schizophrenia
Location: Staten Island, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-11366
Conditions: Schizophrenia
Location: Fresh Meadows, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-11423
Conditions: Schizophrenia
Location: Holliswood, NY
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-19139
Conditions: Schizophrenia
Location: Philadelphia, PA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20016
Conditions: Schizophrenia
Location: Washington, DC
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20036
Conditions: Schizophrenia
Location: Washington, DC
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30308
Conditions: Schizophrenia
Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30328
Conditions: Schizophrenia
Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30333
Conditions: Schizophrenia
Location: Decatur, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-30342
Conditions: Schizophrenia
Location: Atlanta, GA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-38119
Conditions: Schizophrenia
Location: Memphis, TN
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-39232
Conditions: Schizophrenia
Location: Flowood, MS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-60068
Conditions: Schizophrenia
Location: Park Ridge, IL
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-67207
Conditions: Schizophrenia
Location: Wichita, KS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-67211
Conditions: Schizophrenia
Location: Wichita, KS
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-73034
Conditions: Schizophrenia
Location: Edmond, OK
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-73116
Conditions: Schizophrenia
Location: Oklahoma City, OK
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-77008
Conditions: Schizophrenia
Location: Houston, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-77401
Conditions: Schizophrenia
Location: Bellaire, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-78731
Conditions: Schizophrenia
Location: Austin, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-78754
Conditions: Schizophrenia
Location: Austin, TX
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-89102
Conditions: Schizophrenia
Location: Las Vegas, NV
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-89128
Conditions: Schizophrenia
Location: Las Vegas, NV
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90502
Conditions: Schizophrenia
Location: Torrance, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90703
Conditions: Schizophrenia
Location: Cerritos, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90723
Conditions: Schizophrenia
Location: Paramount, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90805
Conditions: Schizophrenia
Location: Long Beach, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-90808
Conditions: Schizophrenia
Location: Long Beach, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-91436
Conditions: Schizophrenia
Location: Glendale, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-91910
Conditions: Schizophrenia
Location: Chula Vista, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-91950
Conditions: Schizophrenia
Location: National City, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-92025
Conditions: Schizophrenia
Location: Escondido, CA
- A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-92845
Conditions: Schizophrenia
Location: Garden Grove, CA
- A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Patients With Schizophrenia - NCT01116830-10962
Conditions: Schizophrenia
Location: Orangeburg, NY
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia - NCT00538070-02114
Conditions: Schizophrenia
Location: Boston, MA
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia - NCT00538070-02478
Conditions: Schizophrenia
Location: Belmont, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02114
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Boston, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02130
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Jamaica Plain, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-03063
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Nashua, NH
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-49503
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Grand Rapids, MI
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-55454
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking
Location: Minneapolis, MN
- Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia - NCT00149734-80220
Conditions: Schizophrenia
Location: Denver, CO
- Add-on Simvastatin in Schizophrenia Trial - NCT00605995-10032
Conditions: Schizophrenia
Location: New York, NY
- An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children - NCT01050582-
Conditions: Schizophrenia - Bipolar Disorder - Autistic Disorder - Attention Deficit and Disruptive Behavior Disorders
Location: Columbus, OH
- An Open Trial of Cysteamine Treatment in Schizophrenia - NCT01139125-30912
Conditions: Schizophrenia - Schizoaffective
Location: Augusta, GA
- Antipsychotics and Blood Vessel Function - NCT00585273-52242
Conditions: Bipolar Disorder - Schizophrenia
Location: Iowa City, IA
- Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence - NCT00819689-80220
Conditions: Schizophrenia - Cocaine Dependence
Location: Denver, CO
- Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality - NCT01031433-21228
Conditions: Nicotine Dependence
Location: Catonsville, MD
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08852
Conditions: Schizophrenia
Location: Monmouth Junction, NJ
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08901
Conditions: Schizophrenia
Location: New Brunswick, NJ
- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects - NCT00567034-02478
Conditions: Schizophrenia - Psychotic Disorders
Location: Belmont, MA
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21201
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21222
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21228A
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarker Study of Acamprosate in Schizophrenia - NCT00688324-21228B
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Baltimore, MD
- Biomarkers in Schizophrenia - NCT00817336-10962
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Orangeburg, NY
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-06106
Conditions: Schizophrenia - Bipolar
Location: Hartford, CT
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-21201
Conditions: Schizophrenia - Bipolar
Location: Baltimore, MD
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-21228
Conditions: Schizophrenia - Bipolar
Location: Baltimore, MD
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-48201
Conditions: Schizophrenia - Bipolar
Location: Detroit, MI
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-60612
Conditions: Schizophrenia - Bipolar
Location: Chicago, IL
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes - NCT00666432-75390
Conditions: Schizophrenia - Bipolar
Location: Dallas, TX
- Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia - NCT01123317-21228
Conditions: Schizophrenia
Location: Catonsville, MD
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-20003
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases
Location: Washington, DC
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-20892
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases
Location: Bethesda, MD
- Brain Tissue Collection for Neuropathological Studies - NCT00001260-22032
Conditions: Bipolar Disorder - Depression - Anxiety Disorders - Schizophrenia - Tourette's Syndrome - Brain Diseases
Location: Fairfax, VA
- Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia - NCT00588731-06511
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New Haven, CT
- Cannabis and Schizophrenia: Self-Medication and Agonist Treatment - NCT00946348-03756
Conditions: Schizophrenia - Dual Diagnosis - Schizoaffective Disorder - Psychotic Disorder - Cannabis Use Disorder
Location: Lebanon, NH
- Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation - NCT00801567-02478
Conditions: Bipolar Disorder - Schizophrenia - Healthy Controls
Location: Belmont, MA
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-02115
Conditions: Schizophrenia
Location: Boston, MA
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-06519
Conditions: Schizophrenia
Location: New Haven, CT
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-10032
Conditions: Schizophrenia
Location: New York, NY
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-10035
Conditions: Schizophrenia
Location: New York, NY
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-27509
Conditions: Schizophrenia
Location: Butner, NC
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-30912
Conditions: Schizophrenia
Location: Augusta, GA
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-33136
Conditions: Schizophrenia
Location: Miami, FL
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-46222
Conditions: Schizophrenia
Location: Indianapolis, IN
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-55454
Conditions: Schizophrenia
Location: Minneapolis, MN
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-60611
Conditions: Schizophrenia
Location: Chicago, IL
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-60612
Conditions: Schizophrenia
Location: Chicago, IL
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-65212
Conditions: Schizophrenia
Location: Columbia, MO
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-75390
Conditions: Schizophrenia
Location: Dallas, TX
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-78229
Conditions: Schizophrenia
Location: San Antonio, TX
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-91344
Conditions: Schizophrenia
Location: Granada Hills, CA
- Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia Stabilized on Lurasidone - NCT01173874-92868
Conditions: Schizophrenia
Location: Orange, CA
- Clinical Trial of Tolcapone for Cognition in Schizophrenia - NCT00044083-20892
Conditions: Schizophrenia
Location: Bethesda, MD
- Cognitive Behavior Therapy and Work Outcome - NCT00810355-46202
Conditions: Schizophrenia
Location: Indianapolis, IN
- Cognitive Skills Training Using Computer for Patients With Severe Mental Illness - NCT01036282-10605
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New York, NY
- Cognitive Therapy for Negative Symptoms and Functioning - NCT00350883-19104
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Philadelphia, PA
- Cognitive Training to Enhance VA Work Program Outcomes - NCT00829400-06516
Conditions: Mental Illness - Schizophrenia - Depression - PTSD - Bipolar Disorder
Location: West Haven, CT
- Cognitive-Behavioral Therapy in Veterans With Schizophrenia - NCT00688259-90073
Conditions: Schizophrenia - Schizoaffective Disorder
Location: West Los Angeles, CA
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-07018
Conditions: Schizophrenia
Location: East Orange, NJ
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11004
Conditions: Schizophrenia
Location: Glen Oaks, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11030
Conditions: Schizophrenia
Location: Manhasset, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11212
Conditions: Schizophrenia
Location: Brooklyn, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-11418
Conditions: Schizophrenia
Location: Jamaica, NY
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis - NCT00320671-78229
Conditions: Schizophrenia
Location: San Antonio, TX
- Comparison of Video Consent Versus Routine Consent for Participation in Research Studies - NCT00430391-92161
Conditions: Schizophrenia
Location: San Diego, CA
- Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill - NCT00809770-98104
Conditions: Drug Abuse - Schizophrenia - Bipolar Disorder - Major Depressive Disorder
Location: Seattle, WA
- Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia - NCT00136760-02912
Conditions: Schizophrenia and Disorders With Psychotic Features - Tobacco Use Disorder
Location: Providence, RI
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning - NCT00937261-92697
Conditions: Schizophrenia
Location: Irvine, CA
- Coronary Artery Disease (CAD) Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation - NCT00167310-15206
Conditions: Schizophrenia - Schizoaffective Disorder - Major Depression - Bipolar Disorder - Coronary Artery Disease
Location: Pittsburgh, PA
- CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness - NCT01149551-10468
Conditions: Schizophrenia - Bipolar Disorder
Location: Bronx, NY
- Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia - NCT00356317-33146
Conditions: Schizophrenia
Location: Coral Gables, FL
- D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia - NCT00963924-02114
Conditions: Schizophrenia
Location: Boston, MA
- DECIFER: DEpression and Citalopram In First Episode Recovery - NCT01041274-02114
Conditions: Schizophrenia - Schizophreniform Disorder
Location: Boston, MA
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia - NCT00690235-75390
Conditions: Schizophrenia - Schizoaffective Disorder - Diabetes - Weight Gain
Location: Dallas, TX
- Determining Metabolic Effects of Valproate and Antipsychotic Therapy - NCT00167934-63110
Conditions: Schizophrenia
Location: St. Louis, MO
- Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients - NCT00501163-63110
Conditions: Schizophrenia - Cardiovascular Disease
Location: St. Louis, MO
- Dopamine Function and Reward Processing In Schizophrenia - NCT01035996-21201
Conditions: Schizophrenia
Location: Baltimore, MD
- Dopamine Function and Reward Processing In Schizophrenia - NCT01035996-21224
Conditions: Schizophrenia
Location: Baltimore, MD
- D-serine for the Schizophrenia Prodrome - NCT00826202-
Conditions: Schizophrenia Prodrome
Location: Glen Oaks, NY
- D-serine for the Schizophrenia Prodrome - NCT00826202-10962
Conditions: Schizophrenia Prodrome
Location: Orangeburg, NY
- D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia - NCT00237809-06508
Conditions: Schizophrenia - Schizoaffective Disorder
Location: New Haven, CT
- D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia - NCT00237809-06516
Conditions: Schizophrenia - Schizoaffective Disorder
Location: West Haven, CT
- Early Detection and Intervention for the Prevention of Psychosis - NCT00531518-04102
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Portland, ME
- Early Detection and Intervention for the Prevention of Psychosis - NCT00531518-11004
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Glen Oaks, NY
- Early Detection and Intervention for the Prevention of Psychosis - NCT00531518-48108
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Ann Arbor, MI
- Early Detection and Intervention for the Prevention of Psychosis - NCT00531518-87131
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Albuquerque, NM
- Early Detection and Intervention for the Prevention of Psychosis - NCT00531518-95817
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Sacramento, CA
- Early Detection and Intervention for the Prevention of Psychosis - NCT00531518-97301
Conditions: Schizophrenia - Bipolar Disorder - Depression - Psychotic Disorders
Location: Salem, OR
- Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia - NCT01163227-08046
Conditions: Schizophrenia Disorders
Location: Willingboro, NJ
- Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia - NCT01163227-91206
Conditions: Schizophrenia Disorders
Location: Glendale, CA
- Effectiveness and Safety of Flexible Doses of Paliperidone Prolonged Release in Adolescent Patients With Schizophrenia - NCT01009047-
Conditions: Schizophrenia
Location: Shreveport, LA
- Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia - NCT00338832-92093
Conditions: Schizophrenia
Location: La Jolla, CA
- Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis - NCT00655239-94591
Conditions: Schizophrenia
Location: San Francisco, CA
- Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis - NCT00655239-95817
Conditions: Schizophrenia
Location: Davis, CA
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-10029
Conditions: Schizophrenia - Psychotic Disorders
Location: New York, NY
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-10035
Conditions: Schizophrenia - Psychotic Disorders
Location: New York, NY
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - NCT00158223-11717
Conditions: Schizophrenia - Psychotic Disorders
Location: W. Brentwood, NY
- Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia - NCT00312962-94121
Conditions: Schizophrenia
Location: San Francisco, CA
- Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia - NCT00435370-77030
Conditions: Smoking Cessation - Schizophrenia
Location: Houston, TX
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-02114
Conditions: Schizophrenia
Location: Boston, MA
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-14623
Conditions: Schizophrenia
Location: Rochester, NY
- Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia - NCT00611806-49503
Conditions: Schizophrenia
Location: Grand Rapids, MI
- Effects of Delta-9-THC and Iomazenil in Healthy Humans - NCT00982982-06516
Conditions: Schizophrenia - Mental Disorders - Psychotic Disorders
Location: West Haven, CT
- Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia - NCT00833547-02114
Conditions: Schizophrenia
Location: Boston, MA
- Effects of Galantamine on Cognition - NCT01100775-21228
Conditions: Schizophrenia
Location: Baltimore, MD
- Effects of Modafinil on Brain Function in Patients With Schizophrenia - NCT00057707-20892
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Bethesda, MD
- Effects of Motivating People With Schizophrenia to Exercise - NCT00559572-37917
Conditions: Schizophrenia
Location: Knoxville, TN
- Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia - NCT01034085-21201
Conditions: Nicotine Dependence - Schizophrenia
Location: Baltimore, MD
- Effects of Oxytocin Nasal Spray on Social Affiliation - NCT00663039-21228
Conditions: Schizophrenia
Location: Catonsville, MD
- Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia - NCT01082588-02114
Conditions: Schizophrenia - Schizoaffective Disorders - Schizophreniform Disorders
Location: Boston, MA
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia - NCT00148083-10605
Conditions: Schizophrenia - Schizoaffective Disorder
Location: White Plains, NY
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia - NCT00148083-60612
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Chicago, IL
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia - NCT00770237-21228
Conditions: Schizophrenia - Nicotine Dependence
Location: Catonsville, MD
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-10454
Conditions: Schizophrenia
Location: Bronx, NY
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-11516
Conditions: Schizophrenia
Location: Cedarhurst, NY
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-12001
Conditions: Schizophrenia
Location: Pittsfield, MA
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-19131
Conditions: Schizophrenia
Location: Philadelphia, PA
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-29405
Conditions: Schizophrenia
Location: Charleston, SC
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-45408
Conditions: Schizophrenia
Location: Dayton, OH
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-60640A
Conditions: Schizophrenia
Location: Chicago, IL
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-60640B
Conditions: Schizophrenia
Location: Oklahoma City, OK
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-63139
Conditions: Schizophrenia
Location: St Louis, MO
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-71104
Conditions: Schizophrenia
Location: Shreveport, LA
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-75115
Conditions: Schizophrenia
Location: DeSota, TX
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-77008
Conditions: Schizophrenia
Location: Houston, TX
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-78754
Conditions: Schizophrenia
Location: Austin, TX
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-78756
Conditions: Schizophrenia
Location: Austin, TX
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia - NCT01077700-90660
Conditions: Schizophrenia
Location: Pico Rivera, CA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|